NIRS is having a renaissance;but not all the pieces are moving at the same speed

Near-infrared has been a staple in many industries for over four decades but has lagged behind in the other, consumer-based industries. One reason is that the Pharma industry is highly regulated and producers have been hesitant to attempt any changes. Since 2004, numerous guidances from the FDA and EMA, along with guidelines from the International Council for Harmonisation, have encouraged and, in reality, given permission to the Pharma industry to enter the 21st century. Together with financial pressures, available technologies are moving the industry to new levels of quality and safety (and profit).